Matches in SemOpenAlex for { <https://semopenalex.org/work/W3142505488> ?p ?o ?g. }
- W3142505488 abstract "Type III interferons have been touted as promising therapeutics in outpatients with coronavirus disease 2019 (COVID-19). We conducted a randomized, single-blind, placebo-controlled trial (NCT04331899) in 120 outpatients with mild to moderate COVID-19 to determine whether a single, 180 mcg subcutaneous dose of Peginterferon Lambda-1a (Lambda) within 72 hours of diagnosis could shorten the duration of viral shedding (primary endpoint) or symptoms (secondary endpoint). In both the 60 patients receiving Lambda and 60 receiving placebo, the median time to cessation of viral shedding was 7 days (hazard ratio [HR] = 0.81; 95% confidence interval [CI] 0.56 to 1.19). Symptoms resolved in 8 and 9 days in Lambda and placebo, respectively, and symptom duration did not differ significantly between groups (HR 0.94; 95% CI 0.64 to 1.39). Both Lambda and placebo were well-tolerated, though liver transaminase elevations were more common in the Lambda vs. placebo arm (15/60 vs 5/60; p = 0.027). In this study, a single dose of subcutaneous Peginterferon Lambda-1a neither shortened the duration of SARS-CoV-2 viral shedding nor improved symptoms in outpatients with uncomplicated COVID-19." @default.
- W3142505488 created "2021-04-13" @default.
- W3142505488 creator A5002136363 @default.
- W3142505488 creator A5002509563 @default.
- W3142505488 creator A5006919099 @default.
- W3142505488 creator A5011693820 @default.
- W3142505488 creator A5014337862 @default.
- W3142505488 creator A5026667682 @default.
- W3142505488 creator A5029316595 @default.
- W3142505488 creator A5032969374 @default.
- W3142505488 creator A5037723209 @default.
- W3142505488 creator A5038399044 @default.
- W3142505488 creator A5054182272 @default.
- W3142505488 creator A5054307159 @default.
- W3142505488 creator A5055918467 @default.
- W3142505488 creator A5056033264 @default.
- W3142505488 creator A5062528386 @default.
- W3142505488 creator A5062822575 @default.
- W3142505488 creator A5063348920 @default.
- W3142505488 creator A5065283769 @default.
- W3142505488 creator A5068012825 @default.
- W3142505488 creator A5068681527 @default.
- W3142505488 creator A5072636408 @default.
- W3142505488 creator A5072986625 @default.
- W3142505488 creator A5073586334 @default.
- W3142505488 creator A5079007877 @default.
- W3142505488 creator A5080080229 @default.
- W3142505488 creator A5080667439 @default.
- W3142505488 creator A5090463107 @default.
- W3142505488 date "2021-03-30" @default.
- W3142505488 modified "2023-10-12" @default.
- W3142505488 title "Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial" @default.
- W3142505488 cites W1971259949 @default.
- W3142505488 cites W1994292458 @default.
- W3142505488 cites W2013202475 @default.
- W3142505488 cites W2044021955 @default.
- W3142505488 cites W2063671198 @default.
- W3142505488 cites W2100396313 @default.
- W3142505488 cites W2131733302 @default.
- W3142505488 cites W2221378786 @default.
- W3142505488 cites W2290466312 @default.
- W3142505488 cites W2517547699 @default.
- W3142505488 cites W2936804536 @default.
- W3142505488 cites W3001195213 @default.
- W3142505488 cites W3010839841 @default.
- W3142505488 cites W3014846055 @default.
- W3142505488 cites W3015280639 @default.
- W3142505488 cites W3015348407 @default.
- W3142505488 cites W3016467573 @default.
- W3142505488 cites W3019077945 @default.
- W3142505488 cites W3021626303 @default.
- W3142505488 cites W3023606094 @default.
- W3142505488 cites W3025395896 @default.
- W3142505488 cites W3027829318 @default.
- W3142505488 cites W3030537287 @default.
- W3142505488 cites W3031713996 @default.
- W3142505488 cites W3033731522 @default.
- W3142505488 cites W3034312608 @default.
- W3142505488 cites W3034873991 @default.
- W3142505488 cites W3034927885 @default.
- W3142505488 cites W3035343971 @default.
- W3142505488 cites W3037578804 @default.
- W3142505488 cites W3041960835 @default.
- W3142505488 cites W3043399375 @default.
- W3142505488 cites W3047880178 @default.
- W3142505488 cites W3048230590 @default.
- W3142505488 cites W3048795936 @default.
- W3142505488 cites W3081073771 @default.
- W3142505488 cites W3087862874 @default.
- W3142505488 cites W3088256443 @default.
- W3142505488 cites W3103598365 @default.
- W3142505488 cites W3105885548 @default.
- W3142505488 cites W3111431752 @default.
- W3142505488 cites W4233800959 @default.
- W3142505488 doi "https://doi.org/10.1038/s41467-021-22177-1" @default.
- W3142505488 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8009873" @default.
- W3142505488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33785743" @default.
- W3142505488 hasPublicationYear "2021" @default.
- W3142505488 type Work @default.
- W3142505488 sameAs 3142505488 @default.
- W3142505488 citedByCount "93" @default.
- W3142505488 countsByYear W31425054882021 @default.
- W3142505488 countsByYear W31425054882022 @default.
- W3142505488 countsByYear W31425054882023 @default.
- W3142505488 crossrefType "journal-article" @default.
- W3142505488 hasAuthorship W3142505488A5002136363 @default.
- W3142505488 hasAuthorship W3142505488A5002509563 @default.
- W3142505488 hasAuthorship W3142505488A5006919099 @default.
- W3142505488 hasAuthorship W3142505488A5011693820 @default.
- W3142505488 hasAuthorship W3142505488A5014337862 @default.
- W3142505488 hasAuthorship W3142505488A5026667682 @default.
- W3142505488 hasAuthorship W3142505488A5029316595 @default.
- W3142505488 hasAuthorship W3142505488A5032969374 @default.
- W3142505488 hasAuthorship W3142505488A5037723209 @default.
- W3142505488 hasAuthorship W3142505488A5038399044 @default.
- W3142505488 hasAuthorship W3142505488A5054182272 @default.
- W3142505488 hasAuthorship W3142505488A5054307159 @default.
- W3142505488 hasAuthorship W3142505488A5055918467 @default.
- W3142505488 hasAuthorship W3142505488A5056033264 @default.
- W3142505488 hasAuthorship W3142505488A5062528386 @default.